← Leaderboards
Lingtao Jin
University Of Texas Hlth Science Center
$5,208,894
Attributed
$6,074,982
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,074,982 · 3
By mechanism
R01$3,549,645 · 2
R37$2,525,337 · 1
Top collaborators
- Shuang Huang4 shared
Most similar at University Of Texas Hlth Science Center
Same institution · by research overlap
- Anand Kornepati$129,544
- Peter J Houghton$32,798,876
- Kristin Ann Altwegg$51,460
- Neelam Mukherjee$778,615
- William Brian Reeves$8,840,061
Others in their field
Other Emerging Leaders on “Signal Transduction”
- Yunda Huang · Fred Hutchinson Cancer Center$53,064,276
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
- Leonard Freedman · Leidos Biomedical Research, Inc.$32,575,497
- Bala Raja · Luminostics, Inc.$28,624,460
- Suzanne L Baker · University Of Pittsburgh At Pittsburgh$20,465,582
Research focus
Signal TransductionMediatingPlatinumMolecularTp53 GeneTherapeutic TargetProteinsIn VitroPreventEfficacy EvaluationCancer PatientResistanceKnock-DownPhosphorylationInhibitorResponseDrug RepurposingRecurrenceCancer Cell LineProteomicsPlayPhosphotransferasesScreeningChemotherapy
Grant awards (16)
The role of NFIB-MAST1 signaling in mediating adaptive cisplatin resistance in SCLC$375,936
R37 · FY2025 · CA · contact PI
Platinum-induced lipid reprogramming and tumor immune microenvironment in SCLC$351,245
R01 · FY2025 · CA · contact PI
Novel protein kinase signaling associated with platinum resistance in ovarian cancer$420,861
R01 · FY2024 · CA
The role of NFIB-MAST1 signaling in mediating adaptive cisplatin resistance in SCLC$336,246
R37 · FY2024 · CA · contact PI
Platinum-induced lipid reprogramming and tumor immune microenvironment in SCLC$334,978
R01 · FY2024 · CA · contact PI
Novel protein kinase signaling associated with platinum resistance in ovarian cancer$434,151
R01 · FY2023 · CA
The role of platinum-regulated lipid metabolism in tau-related dementia$412,188
R01 · FY2023 · CA · contact PI
Platinum-induced lipid reprogramming and tumor immune microenvironment in SCLC$354,464
R01 · FY2023 · CA · contact PI
The role of NFIB-MAST1 signaling in mediating adaptive cisplatin resistance in SCLC$346,863
R37 · FY2023 · CA · contact PI
Novel protein kinase signaling associated with platinum resistance in ovarian cancer$434,152
R01 · FY2022 · CA
The role of NFIB-MAST1 signaling in mediating adaptive cisplatin resistance in SCLC$367,692
R37 · FY2022 · CA · contact PI
Platinum-induced lipid reprogramming and tumor immune microenvironment in SCLC$364,593
R01 · FY2022 · CA · contact PI
Novel protein kinase signaling associated with platinum resistance in ovarian cancer$443,013
R01 · FY2021 · CA
The functional role of MAST1 in mediating a-synucleinopathies and related dementia$400,912
R37 · FY2021 · CA · contact PI
The role of NFIB-MAST1 signaling in mediating adaptive cisplatin resistance in SCLC$348,844
R37 · FY2021 · CA · contact PI
The role of NFIB-MAST1 signaling in mediating adaptive cisplatin resistance in SCLC$348,844
R37 · FY2020 · CA · contact PI